Evaluation of the effectiveness of risk minimization measures

被引：44

作者：

Prieto, Luis ^{[1
]}

Spooner, Almath ^{[2
]}

Hidalgo-Simon, Ana ^{[1
]}

Rubino, Annalisa ^{[1
]}

Kurz, Xavier ^{[1
]}

Arlett, Peter ^{[1
]}

机构：

[1] European Med Agcy, London E14 4HB, England

[2] Irish Med Board, Dublin, Ireland

来源：

关键词：

risk; risk management; legislation; pharmacovigilance; pharmacoepidemiology; public health;

D O I：

10.1002/pds.3305

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：896 / 899

页数：4

共 18 条

[1]

[Anonymous], 2008, HLTH MEASUREMENT SCA, DOI DOI 10.1093/ACPROF:OSO/9780199231881.001.0001

[2]

[Anonymous], 2008, Modern epidemiology

[3]

[Anonymous], 2010, OfficialJournaloftheEuropeanUnion, VL348, P74

[4]

[Anonymous], 2010, OFFICIAL J L, VL 348, P1

[5]

Bowling A., 2002, RES METHODS HLTH, V2nd

[6]

ENCePP, 2011, CHECKL STUD PROT

[7]

European Medicines Agency (EMA), 2012, GOOD PHARM PRACT

[8]

European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP), 2011, GUID METH STAND PHAR

[9]

European Union Legislation - Eudralex, 2008, RUL GOV MED PROD E A, V9A

[10]

Fowler F.J., 2009, Survey research methods, Vfourth